tetracycline has been researched along with Carcinoma--Basal-Cell* in 3 studies
3 other study(ies) available for tetracycline and Carcinoma--Basal-Cell
| Article | Year |
|---|---|
Tetracycline use and risk of incident skin cancer: a prospective study.
Tetracycline is a photosensitising medication that increases skin vulnerability to UV-related damage.. We prospectively examined tetracycline use and risk of incident melanoma, squamous cell carcinoma (SCC), and basal cell carcinoma (BCC) based on 213 536 participants from the Nurses' Health Study (NHS), NHS2, and Health Professionals Follow-up Study. Information on ever use of tetracycline was asked via questionnaire. Diagnoses of melanoma and SCC were pathologically confirmed.. Tetracycline use was associated with a modestly increased risk of BCC, but was not associated with melanoma or SCC. Topics: Adult; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Humans; Incidence; Male; Melanoma; Middle Aged; Photosensitizing Agents; Prospective Studies; Risk; Skin Neoplasms; Tetracycline; United Kingdom | 2018 |
Contact sensitization to metronidazole from possible occupational exposure.
Topics: Administration, Topical; Adult; Aged; Carcinoma, Basal Cell; Dermatitis, Allergic Contact; Dermatitis, Occupational; Diagnosis, Differential; Facial Dermatoses; Female; Humans; Metronidazole; Nursing; Occupational Exposure; Patch Tests; Rosacea; Skin Neoplasms; Tetracycline | 2009 |
Keratoacanthoma. Association with basal and squamous cell carcinoma.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Humans; Keratoacanthoma; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Nose Neoplasms; Tetracycline | 1969 |